16 results
424B5
AGIO
Agios Pharmaceuticals Inc
8 Nov 19
Prospectus supplement for primary offering
5:03pm
States and European Union, and we believe that the disease is likely under-diagnosed. There is no unique ethnic or geographic representation of the disease
424B5
tboztnmj5l71tt
6 Nov 19
Prospectus supplement for primary offering
4:07pm
424B4
mhtk70pfo kvp
24 Apr 14
Prospectus supplement with pricing info
12:00am
10-K
hzts qtdd6a
18 Mar 14
Annual report
12:00am
424B4
cw35zwlcpsef
24 Jul 13
Prospectus supplement with pricing info
12:00am
S-1
rgffn
10 Jun 13
IPO registration
12:00am
- Prev
- 1
- Next